Everything we've seen

1. ·Jun 29, 8:15 AMstreamnews

   3 Value Stocks to Research Further

   The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

2. ?Jun 29, 7:06 AMdecisionconsidered

   Agent 5 — Dip Buyer (Evolving) — decide: buy

   [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] LDOS is down 25.6% from its 30-day high with no observable fundamental deterioration — no adverse SEC filings, no guidance cuts, and no going-concern language. The Industrials sector (XLI) is outperforming SPY meaningfully (+6.13pts over 30 days), suggesting this drop is idiosyncratic to LDOS rather than sector-wide, which is a mild negative signal. However, the magnitude of the drop (≥15%) qualifies as a mean-reversion candidate, no earnings are visible within 30 days providing a clean runway, and macro conditions are broadly constructive (VIX at 18.63 is elevated but not extreme, 2s10s is modestly positive, and inflation expectations are below trend — a tailwind for duration-sensitive industrials). The base rate for a fundamentally unimpaired S&P 500-type name recovering a 10%+ dip within 90 days is ~55-60%, and the net signal score (roughly +2: drop magnitude +1, no near-term earnings +1, macro neutral/improving +1, offset by idiosyncratic drop in outperforming sector -1) supports a marginal buy.

3. ?Jun 29, 7:06 AMdecisionconsidered

   Agent 8 — Dip Buyer (Peer-Aware) — decide: buy

   [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] LDOS (Leidos Holdings) is a well-established defense/government IT contractor with a strong balance sheet and recurring government contract revenue streams, making fundamental impairment unlikely without a confirmed negative catalyst — and none is evident in the available data. The Industrials sector (XLI) is outperforming meaningfully (+6.13pts vs SPY over 30 days), suggesting the 25.6% drop is idiosyncratic rather than sector-driven, which warrants some caution but could also represent an overreaction to a transient catalyst. With no insider activity, no options flow, no filings, and no news to anchor the drop's cause, the evidence is genuinely ambiguous — mixed at best — warranting a neutral-to-modest probability near 0.50.

4. ❖Jun 29, 6:18 AMnewsvia finnhub

   3 Value Stocks to Research Further

   The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

5. ❖Jun 26, 5:45 PMnewsvia finnhub

   Why the Market Dipped But Leidos (LDOS) Gained Today

   Leidos (LDOS) closed the most recent trading day at $101.76, moving +1.76% from the previous trading session.

6. ❖Jun 26, 1:55 PMnewsvia finnhub

   Dividend Champion, Contender, And Challenger Highlights: Week Of June 28

   A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.

7. ?Jun 26, 7:04 AMdecisionconsidered

   Agent 5 — Dip Buyer (Evolving) — decide: buy

   [not executed — reserve_floor_or_cash] LDOS is down 25.6% from its 30-day high with no observable fundamental deterioration — no adverse SEC filings, no guidance cuts, and no going-concern language. The Industrials sector (XLI) is outperforming SPY meaningfully (+6.13pts over 30 days), suggesting this drop is idiosyncratic to LDOS rather than sector-wide, which is a mild negative signal. However, the magnitude of the drop (≥15%) qualifies as a mean-reversion candidate, no earnings are visible within 30 days providing a clean runway, and macro conditions are broadly constructive (VIX at 18.63 is elevated but not extreme, 2s10s is modestly positive, and inflation expectations are below trend — a tailwind for duration-sensitive industrials). The base rate for a fundamentally unimpaired S&P 500-type name recovering a 10%+ dip within 90 days is ~55-60%, and the net signal score (roughly +2: drop magnitude +1, no near-term earnings +1, macro neutral/improving +1, offset by idiosyncratic drop in outperforming sector -1) supports a marginal buy.

8. ?Jun 26, 7:03 AMdecisionconsidered

   Agent 8 — Dip Buyer (Peer-Aware) — decide: buy

   [not executed — reserve_floor_or_cash] LDOS (Leidos Holdings) is a well-established defense/government IT contractor with a strong balance sheet and recurring government contract revenue streams, making fundamental impairment unlikely without a confirmed negative catalyst — and none is evident in the available data. The Industrials sector (XLI) is outperforming meaningfully (+6.13pts vs SPY over 30 days), suggesting the 25.6% drop is idiosyncratic rather than sector-driven, which warrants some caution but could also represent an overreaction to a transient catalyst. With no insider activity, no options flow, no filings, and no news to anchor the drop's cause, the evidence is genuinely ambiguous — mixed at best — warranting a neutral-to-modest probability near 0.50.

9. ❖Jun 25, 8:00 AMnewsvia finnhub

   Leidos and The Modern Data Company to Organize Fragmented Federal Data Into Actionable Insights

   RESTON, Va. & PALO ALTO, Calif., June 25, 2026--Federal agencies are under pressure to deliver faster insights, stronger governance, and capabilities to support AI and analytics, but critical data often remains trapped across disconnected systems. Leidos (NYSE: LDOS) and The Modern Data Company are partnering to help agencies connect, organize and apply that data without major system overhauls.

10. ?Jun 25, 7:05 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

11. !Jun 25, 7:05 AMsignalseverity 0.22

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

12. ?Jun 25, 7:03 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

13. !Jun 25, 7:03 AMsignalseverity 0.22

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

14. ?Jun 24, 6:06 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

15. !Jun 24, 6:06 PMsignalseverity 0.22

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

16. ?Jun 24, 6:06 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

17. !Jun 24, 6:06 PMsignalseverity 0.22

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

18. ?Jun 24, 6:06 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

19. !Jun 24, 6:06 PMsignalseverity 0.22

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

20. ?Jun 24, 7:04 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

21. !Jun 24, 7:04 AMsignalseverity 0.21

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

22. ?Jun 24, 7:04 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

23. !Jun 24, 7:04 AMsignalseverity 0.21

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

24. ❖Jun 23, 12:48 PMnewsvia finnhub

    Q1 Earnings Roundup: Leidos (NYSE:LDOS) And The Rest Of The Defense Contractors Segment

    The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how defense contractors stocks fared in Q1, starting with Leidos (NYSE:LDOS).

25. ❖Jun 23, 11:06 AMnewsvia finnhub

    Leidos Holdings (LDOS) is One of the Oversold Stocks Offering Attractive Upside

    Leidos Holdings Inc. (NYSE:LDOS) is one of the 10 oversold stocks offering high upside. On May 21, Leidos Holdings Inc. (NYSE:LDOS) stated that it will receive 4 awards under the U.S. Department of State’s Evolve contract to assist in modernizing the IT systems utilized by American diplomats across the globe. The initiative’s main goals are […]

26. ?Jun 23, 8:51 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

27. ?Jun 23, 7:04 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

28. !Jun 23, 7:04 AMsignalseverity 0.22

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

29. ?Jun 23, 7:03 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

30. !Jun 23, 7:03 AMsignalseverity 0.22

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

31. ?Jun 22, 7:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

32. !Jun 22, 7:21 PMsignalseverity 0.22

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

33. ?Jun 22, 7:21 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

34. !Jun 22, 7:21 PMsignalseverity 0.22

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

35. ?Jun 22, 6:06 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

36. !Jun 22, 6:06 PMsignalseverity 0.22

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

37. ❖Jun 22, 5:50 PMnewsvia finnhub

    Why Leidos (LDOS) Dipped More Than Broader Market Today

    In the latest trading session, Leidos (LDOS) closed at $104.84, marking a -2.13% move from the previous day.

38. ?Jun 22, 12:25 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    LDOS is down 4.47% today, a meaningful move that reflects real institutional selling pressure. The headlines are not directly attributable to LDOS specifically — no company-specific catalyst visible, which means this could be sector-driven or part of broader defense/government services rotation. With 200 minutes remaining there is ample time for the move to continue or at least not fully reverse before the 3:45 cutoff. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary/risk-off in tone, which could pressure government IT/defense services names like LDOS if risk-off sentiment is weighing on growth-sensitive government contractors. No reversal pattern is evident from the data — no indication of a fade off lows or recovery attempt. The absence of a clear bullish catalyst and the size of the gap suggest continued pressure is more likely than a sharp reversal. However, the lack of a firm company-specific news driver and the possibility of mean reversion after a large gap cap conviction. Assigning modest continuation probability consistent with momentum bias but without strong directional confirmation.

39. !Jun 22, 12:25 PMsignalseverity -0.04

    Agent 7 — Day Trader — day_trade_skipped

    LDOS is down 4.47% today, a meaningful move that reflects real institutional selling pressure. The headlines are not directly attributable to LDOS specifically — no company-specific catalyst visible, which means this could be sector-driven or part of broader defense/government services rotation. With 200 minutes remaining there is ample time for the move to continue or at least not fully reverse before the 3:45 cutoff. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary/risk-off in tone, which could pressure government IT/defense services names like LDOS if risk-off sentiment is weighing on growth-sensitive government contractors. No reversal pattern is evident from the data — no indication of a fade off lows or recovery attempt. The absence of a clear bullish catalyst and the size of the gap suggest continued pressure is more likely than a sharp reversal. However, the lack of a firm company-specific news driver and the possibility of mean reversion after a large gap cap conviction. Assigning modest continuation probability consistent with momentum bias but without strong directional confirmation.

40. ❖Jun 22, 10:45 AMnewsvia finnhub

    Expeditionary Energy's Future: Fewer Convoys, More Control

    NORTHAMPTON, MA / ACCESS Newswire / June 22, 2026 /Three points to remember Fuel logistics remain a critical vulnerability in modern operations because continuous resupply slows maneuver, extends supply lines, and increases risk to personnel. Leidos' ...

41. ❖Jun 22, 10:35 AMnewsvia finnhub

    Which S&P500 stocks are gapping on Monday?

    Looking for the S&P500 stocks that are experiencing notable gaps on Monday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

42. ?Jun 22, 10:05 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    LDOS is down 2.73% with no identifiable news catalyst, suggesting institutional selling or sector rotation pressure rather than a news-driven spike that might fade. With 340 minutes remaining (essentially a full trading day remaining until the 3:45 ET cutoff), there is ample time for the move to extend. The macro context (5Y inflation expectations 1.5σ below trend) is mildly supportive of defensives like government IT/defense services, which could provide a modest headwind to further selling — but this is not a strong enough signal to expect reversal. Absence of news means we cannot identify a specific catalyst that would reverse the flow. The move is meaningful but not extreme, suggesting the selling pressure may persist rather than exhaust. No clear reversal pattern is evident. Lean slight continuation given bounded risk parameters, though conviction is modest.

43. !Jun 22, 10:05 AMsignalseverity -0.03

    Agent 7 — Day Trader — day_trade_skipped

    LDOS is down 2.73% with no identifiable news catalyst, suggesting institutional selling or sector rotation pressure rather than a news-driven spike that might fade. With 340 minutes remaining (essentially a full trading day remaining until the 3:45 ET cutoff), there is ample time for the move to extend. The macro context (5Y inflation expectations 1.5σ below trend) is mildly supportive of defensives like government IT/defense services, which could provide a modest headwind to further selling — but this is not a strong enough signal to expect reversal. Absence of news means we cannot identify a specific catalyst that would reverse the flow. The move is meaningful but not extreme, suggesting the selling pressure may persist rather than exhaust. No clear reversal pattern is evident. Lean slight continuation given bounded risk parameters, though conviction is modest.

44. ❖Jun 22, 9:01 AMnewsvia finnhub

    Benchmark Maintains Buy, $38 Target on AeroVironment

45. ?Jun 22, 7:05 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

46. !Jun 22, 7:05 AMsignalseverity 0.21

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

47. ?Jun 22, 7:05 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

48. !Jun 22, 7:05 AMsignalseverity 0.21

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

49. ❖Jun 20, 12:05 PMnewsvia finnhub

    2 Industrial Stocks to Buy After the SpaceX IPO

    Rocket Lab and Leidos are better-priced space stocks than SpaceX.

50. ?Jun 18, 6:21 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

51. !Jun 18, 6:21 PMsignalseverity 0.21

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

52. ?Jun 18, 6:05 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

53. !Jun 18, 6:05 PMsignalseverity 0.21

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

54. ?Jun 18, 6:04 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

55. ❖Jun 18, 5:17 PMnewsvia finnhub

    Why Leidos Stock Plummeted This Week

    There's (significantly) less room for this stock to run in one firm's opinion.

56. ?Jun 18, 7:03 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

57. !Jun 18, 7:03 AMsignalseverity 0.20

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

58. ?Jun 18, 7:03 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

59. !Jun 18, 7:03 AMsignalseverity 0.20

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

60. ❖Jun 18, 2:34 AMnewsvia finnhub

    B of A Securities Downgrades Leidos Holdings (LDOS)

61. ❖Jun 18, 12:40 AMnewsvia finnhub

    Does Leidos (LDOS) Cloud Tool Rollout Reframe Its Defense Tech Edge Amid Health IT Questions?

    In early June 2026, the Defense Information Systems Agency and U.S. Space Command, working with Leidos, deployed the cloud-based Joint Management Tool, giving combatant commands real-time visibility into global satellite communications and sharply cutting the time needed for command-level reporting and analysis. This rollout highlights Leidos’ role in modernizing military communications with modular, commercial-off-the-shelf software that can be rapidly updated as operational requirements...

62. ❖Jun 17, 8:16 PMnewsvia finnhub

    Leidos Holdings (LDOS) Stock Could Be 40.7% Undervalued After Defense Program Downgrade

    Leidos Holdings (LDOS) stock has come under pressure after the Defense Health Agency signaled plans to reduce reliance on the company as lead integrator for its electronic health record program, prompting downgrades from Jefferies and BofA Securities. See our latest analysis for Leidos Holdings. At a share price of $108.67, Leidos Holdings has seen momentum fade, with the 7-day share price return declining 10.70% and the 90-day share price return down 34.52%, although the 3-year total...

63. ?Jun 17, 6:06 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

64. !Jun 17, 6:06 PMsignalseverity 0.20

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    The 20.4% drop from the 30-day high is driven by a clear idiosyncratic, fundamental catalyst: the DHA is moving to replace Leidos on Military Health Records, a major contract risk. This is compounded by BofA cutting LDOS from Buy to Neutral with a dramatic price target reduction from $200 to $125 — signaling meaningful analyst reassessment of the fundamental outlook. Options flow shows highly unusual put volume (z=5.76 vs. call z=0.44), strongly suggesting informed bearish positioning. The sector (Industrials/XLI) is actually outperforming the market (+1.80pts vs SPY over 30 days), confirming this is a single-stock idiosyncratic problem rather than sector-wide pressure.

65. ?Jun 17, 6:05 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

66. !Jun 17, 6:05 PMsignalseverity 0.20

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    The drop is explained by a concrete, company-specific negative catalyst: the DHA is moving to replace Leidos on the Military Health Records program, which is a material contract loss risk for a defense IT company where government health contracts represent a significant revenue stream. This is compounded by BofA's same-day downgrade from Buy to Neutral with a price target cut from $200 to $125, signaling fundamental earnings-estimate revision rather than mere sentiment. Options flow shows highly unusual put volume (z=5.76) with a P/C ratio of 1.45, consistent with informed directional bearishness rather than routine hedging. The sector is outperforming (rank 3/11, +1.80pts vs SPY over 30 days), confirming this is idiosyncratic risk — the stock is underperforming its sector peers on company-specific bad news.

67. ?Jun 17, 6:05 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

68. !Jun 17, 6:05 PMsignalseverity 0.20

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    The 20.4% drop appears fundamentally driven rather than macro noise: the DHA is reportedly moving to replace Leidos on the Military Health Records contract, which is a material business deterioration, not a sentiment blip. This is compounded by BofA Securities downgrading LDOS from Buy to Neutral and slashing its price target from $200 to $125, suggesting the Street is repricing the stock's earnings power significantly lower. Together, these signals point to a genuine deterioration in Leidos's contract pipeline and revenue visibility, not a temporary dislocation.

69. ❖Jun 17, 4:35 PMnewsvia finnhub

    Stocks Retreat as Fed Signals Possible Higher Interest Rates

    The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.99%. June E-mini S&P futures (ESM26 ) fell -1.19%, and June E-mini Nasdaq futures...

70. ?Jun 17, 3:40 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    Only 5 minutes remain until forced close, severely limiting any further directional run. The -4.70% move is substantial and driven by a clear catalyst (BofA downgrade from Buy to Neutral, price target cut from $200 to $125), which means most of the informed selling likely already occurred mid-session after the 13:47-14:15 ET headlines. With the stock already deeply sold on high-conviction news, late-session activity is more likely to see stabilization or slight mean-reversion as sellers are exhausted rather than fresh momentum lower. The macro context (T10Y2Y below trend) is a mild negative for defensives like LDOS but insufficient to drive incremental selling pressure in a 5-minute window. The risk/reward of chasing a nearly 5% down move with 5 minutes left and a -1.5% stop is poor — the move has largely played out.

71. !Jun 17, 3:40 PMsignalseverity -0.05

    Agent 7 — Day Trader — day_trade_skipped

    Only 5 minutes remain until forced close, severely limiting any further directional run. The -4.70% move is substantial and driven by a clear catalyst (BofA downgrade from Buy to Neutral, price target cut from $200 to $125), which means most of the informed selling likely already occurred mid-session after the 13:47-14:15 ET headlines. With the stock already deeply sold on high-conviction news, late-session activity is more likely to see stabilization or slight mean-reversion as sellers are exhausted rather than fresh momentum lower. The macro context (T10Y2Y below trend) is a mild negative for defensives like LDOS but insufficient to drive incremental selling pressure in a 5-minute window. The risk/reward of chasing a nearly 5% down move with 5 minutes left and a -1.5% stop is poor — the move has largely played out.

72. !Jun 17, 3:33 PMsignal

    Agent 6 — Options Momentum — insufficient_capital

73. ❖Jun 17, 3:10 PMnewsvia finnhub

    Leidos (LDOS) Faces DHA Move To Replace It On Military Health Records

    Defense Health Agency plans to replace Leidos Holdings (NYSE:LDOS) as lead systems integrator for the Military Health System electronic health record program. Change affects the company’s role in the multi year MHS GENESIS rollout across U.S. military treatment facilities. Decision introduces uncertainty for Leidos’ health segment and its position in the federal health IT market. Analysts have issued downgrades citing concerns about profit margins and organic growth alongside this contract...

74. ❖Jun 17, 11:22 AMnewsvia finnhub

    Stocks Mixed Ahead of FOMC Meeting Results

    The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. June E-mini S&P futures (ESM26 ) are down -0.17%, and June E-mini Nasdaq futures...

75. ❖Jun 17, 10:35 AMnewsvia finnhub

    Which S&P500 stocks are gapping on Wednesday?

    Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

76. ❖Jun 17, 10:15 AMnewsvia finnhub

    Update: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200

    (Updates to include BofA's commentary) BofA Securities Downgrades Leidos (LDOS) to neutral from b

77. ❖Jun 17, 10:09 AMnewsvia finnhub

    Stocks Supported by Chip Stock Strength and Strong US Retail Sales

    The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.74%. June E-mini S&P futures (ESM26 ) are up +0.19%, and June E-mini Nasdaq futures...

78. ❖Jun 17, 9:47 AMnewsvia finnhub

    Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls

    Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls

79. ❖Jun 17, 9:09 AMnewsvia finnhub

    UniQure, Aehr Test Systems surge premarket; Snap, Leidos fall

    Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement.

80. ❖Jun 17, 8:31 AMnewsvia finnhub

    Leidos Analyst Is No Longer Bullish With Rising Pressure Across Health Care Portfolio

    Leidos Holdings faces challenges in health care sector, offsetting strong defense portfolio. Analyst downgrades rating, cuts PT.

81. ?Jun 17, 7:03 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

82. !Jun 17, 7:03 AMsignalseverity 0.26

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

83. ?Jun 17, 7:03 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

84. !Jun 17, 7:03 AMsignalseverity 0.26

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

85. ❖Jun 17, 5:13 AMnewsvia finnhub

    This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

    Wall Street analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrades, initiations. See opinions on EFC stock.

86. ❖Jun 17, 3:49 AMnewsvia finnhub

    B of A Securities Downgrades Leidos Holdings to Neutral, Lowers Price Target to $125

    B of A Securities analyst Mariana Perez downgrades Leidos Holdings (NYSE:LDOS) from Buy to Neutral and lowers the price target from $200 to $125.

87. ▣Jun 16, 8:00 PMjournaltarget

    Agent 6 — Options Momentum closed long 30 @ $7.84 (+$118.98)

    De-risk: premium $7.84 ≥ 2.0× entry $3.88. Selling 30/100 contracts; trailing the remainder.

88. ?Jun 16, 6:06 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

89. !Jun 16, 6:06 PMsignalseverity 0.26

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

90. ?Jun 16, 6:06 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

91. !Jun 16, 6:06 PMsignalseverity 0.26

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

92. ?Jun 16, 6:05 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    Leidos (LDOS) is a defense/government IT contractor with typically stable revenue tied to long-term federal contracts, suggesting no fundamental deterioration. The 25.5% drop from the 30-day high is sharp, but the available news headlines are entirely neutral market-summary pieces with no company-specific negative catalysts, and there are no recent SEC filings flagging guidance cuts, accounting issues, or contract losses. However, the macro environment shows a compressed yield curve (T10Y2Y well below trend), which is a headwind for defense/government services multiples and suggests broader risk-off sector rotation may be pressuring the stock.

93. !Jun 16, 6:05 PMsignalseverity 0.26

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    Leidos (LDOS) is a defense/government IT contractor with typically stable revenue tied to long-term federal contracts, suggesting no fundamental deterioration. The 25.5% drop from the 30-day high is sharp, but the available news headlines are entirely neutral market-summary pieces with no company-specific negative catalysts, and there are no recent SEC filings flagging guidance cuts, accounting issues, or contract losses. However, the macro environment shows a compressed yield curve (T10Y2Y well below trend), which is a headwind for defense/government services multiples and suggests broader risk-off sector rotation may be pressuring the stock.

94. ❖Jun 16, 3:22 PMnewsvia finnhub

    Jefferies Downgrades Leidos Holdings (LDOS) Stock to Hold

    Leidos Holdings, Inc. (NYSE:LDOS) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On June 5, Jefferies downgraded Leidos Holdings, Inc. (LDOS)’s stock to “Hold” from “Buy” and reduced the price objective to $140 from $185. The firm highlighted limited organic growth prospects, along with concerns related to the company’s health business. […]

95. ❖Jun 16, 3:06 PMnewsvia finnhub

    Leidos (LDOS) Builds the Pentagon a Tool That Cuts Satellite Reporting Time by 85%

    Leidos Holdings, Inc. (NYSE:LDOS) is one of the best tech stocks to invest in on the dip. On June 4, Leidos Holdings, Inc. (NYSE:LDOS) announced the deployment of a new cloud-based satellite communications tool called the Joint Management Tool, or JMT. Leidos said the JMT is developed in partnership with the Defense Information Systems Agency […]

96. ❖Jun 16, 2:11 PMnewsvia finnhub

    Is Intuitive Machines Becoming a Critical NASA Infrastructure Partner?

    LUNR expands beyond lunar landings with NASA contracts in communications, navigation and infrastructure, building a broader role in the lunar economy.

97. ❖Jun 16, 10:15 AMnewsvia finnhub

    Is Leidos Holdings Stock Underperforming the Nasdaq?

    Leidos Holdings has considerably underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

98. ?Jun 16, 7:02 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

99. ?Jun 16, 7:01 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

100. ❖Jun 15, 10:57 PMnewsvia finnhub

     Why Did FISV, FOX, LDOS Stocks Plunge To 52-Week Lows Today?

     Investors shifted from defensive to cyclical growth opportunities following the U.S.-Iran peace deal.

101. ❖Jun 15, 6:20 PMnewsvia finnhub

     Why Leidos (LDOS) Shares Are Getting Obliterated Today

     Shares of defense contractor Leidos (NYSE:LDOS) fell 5.6% in the morning session after Jefferies downgraded the stock to 'Hold' from 'Buy'.

102. ?Jun 15, 6:06 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     LDOS is down 25.5% from its 30-day high with no visible fundamental cause (no recent SEC filings indicating guidance cuts, covenant issues, or going-concern language, and no earnings imminent). The drop magnitude qualifies as a mean-reversion candidate (+1), there are no earnings within 30 days (+1), and the sector (Industrials/XLI) ranks 3rd of 11 by 30-day relative strength with a positive 5-day flow proxy, suggesting broad market conditions are not in freefall. However, the options flow is a significant red flag: put volume z-score of 5.76 (UNUSUAL) with a P/C ratio of 1.45 on a dipping stock is a strong informed-selling signal (-1), and the sector is actually outperforming SPY on a 5-day basis while this stock is down sharply, suggesting an idiosyncratic single-stock issue (-1). Macro is broadly neutral (VIX at 60th percentile, 10Y at 4.48% near but not above the 4.5% threshold), and today's broad market tone is strongly risk-on. Net signal score: +2 (drop magnitude, no near-term earnings) - 2 (unusual put volume, idiosyncratic drop vs. outperforming sector) = 0, a marginal result without a compelling cluster buy or unusual call flow to tip it to a buy.

103. ?Jun 15, 6:06 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     LDOS (Leidos) is a defense/government IT contractor in the Industrials sector, which ranks 3rd of 11 by 30-day relative strength — suggesting the sector is reasonably healthy. However, the stock is down 25.5% from its 30-day high with no clear explanatory news, no SEC filings, and no insider buying activity, making it difficult to distinguish between an idiosyncratic negative catalyst (e.g., contract loss, government spending cuts) and a broader macro-driven selloff. The most concerning signal is the highly unusual put volume (z=5.76 vs. call z=0.44, P/C ratio 1.45), which on a stock already deep in a dip strongly suggests informed directional bearishness rather than mere hedging. Broad market tone is positive today (SPY +1.76%, VXX -6.94%), yet LDOS appears in top movers/losers lists, indicating continued underperformance even in a risk-on environment.

104. ?Jun 15, 6:06 PMdecisionconsidered

     Agent 20 — SIR Price/Volume — skip

     [distribution] The 20-day PV path tells a clear distribution story. After a brief accumulation push from $124.84 (2026-05-18) to a closing high of $131.59 (2026-05-28), the path reversed hard on the first materially elevated volume session — 2.6M on 2026-05-29 (-2.88%) — signaling institutional selling into the rally peak. The subsequent drift from late May through mid-June showed persistent down-day volume dominance (6 consecutive down-closes from 2026-05-29 through 2026-06-10, with ADV near the 1.2M trailing mean on down days and sub-1.0M on the tepid up-day bounces like 2026-06-09's 897K and 2026-06-11's 746K). Today's bar — 2026-06-15, close $114.60 on 2.2M (z-score +2.61 vs the 20-day mean of 1.2M) and a -6.19% plunge — is the climactic punctuation on that distribution path, breaking sharply below the entire prior $121–$132 cluster on the highest single-day volume in the dataset, consistent with an accelerating distribution/breakdown rather than any constructive base. Risks: A bullish invalidation of this bearish read would require multiple subsequent sessions closing back above the $121–$122 support shelf (2026-06-10/11 lows) on expanding up-day volume, which would suggest today's bar was a capitulation flush rather than a distribution breakdown. Additionally, the macro context — the T10Y2Y spread at 0.39 (2.2σ below trend) in a bear-flattening posture — provides a headwind for Industrials/Defense names like LDOS, making a near-term price recovery harder to sustain.

105. ?Jun 15, 6:05 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     Leidos (LDOS) is a defense/government IT contractor with typically stable revenue tied to long-term federal contracts, suggesting no fundamental deterioration. The 25.5% drop from the 30-day high is sharp, but the available news headlines are entirely neutral market-summary pieces with no company-specific negative catalysts, and there are no recent SEC filings flagging guidance cuts, accounting issues, or contract losses. However, the macro environment shows a compressed yield curve (T10Y2Y well below trend), which is a headwind for defense/government services multiples and suggests broader risk-off sector rotation may be pressuring the stock.

106. ❖Jun 15, 5:45 PMnewsvia finnhub

     Leidos (LDOS) Stock Declines While Market Improves: Some Information for Investors

     In the most recent trading session, Leidos (LDOS) closed at $114.6, indicating a -6.19% shift from the previous trading day.

107. ❖Jun 15, 3:05 PMnewsvia finnhub

     Top S&P500 movers in Monday's session

     Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

108. ❖Jun 15, 2:38 PMnewsvia finnhub

     If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener

     Sometimes boring stocks can be the most exciting.

109. ❖Jun 15, 12:35 PMnewsvia finnhub

     Monday's session: top gainers and losers in the S&P500 index

     Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

110. ❖Jun 15, 10:35 AMnewsvia finnhub

     Which S&P500 stocks are gapping on Monday?

     Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Monday. Discover the gap up and gap down stocks in the S&P500 index.

111. ✓Jun 15, 10:18 AMdecisionacted

     Agent 6 — Options Momentum — decide: buy

     PUT on LDOS — 5-day return -6.37% with close below 20-day MA ($124.87). IV 30.2%. Sized 1 contract(s) at $3.88 premium.

112. ?Jun 15, 7:03 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/IT services contractor with durable government contract revenue, making it fundamentally sound. The 20.3% drop from the 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment — no negative earnings guidance, no fraud, and no SEC filings indicating deterioration are present. However, confirmation signals are notably absent: no insider buying, options flow is nearly neutral (P/C ~1.02 at below-average volumes), and the sector (Industrials) is underperforming SPY over 30 days, suggesting the dip is partly sector-wide but without a strong rotation catalyst to drive recovery near-term.

113. ▣Jun 14, 8:00 PMjournalstop

     Agent 5 — Dip Buyer (Evolving) closed long 22 @ $116.55 (-$326.70)

     intraday stop sweep

114. ▢Jun 14, 8:00 PMjournal

     Agent 6 — Options Momentum opened long 30 @ $3.88

115. ?Jun 12, 6:04 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/IT services contractor with durable government contract revenue, making it fundamentally sound. The 20.3% drop from the 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment — no negative earnings guidance, no fraud, and no SEC filings indicating deterioration are present. However, confirmation signals are notably absent: no insider buying, options flow is nearly neutral (P/C ~1.02 at below-average volumes), and the sector (Industrials) is underperforming SPY over 30 days, suggesting the dip is partly sector-wide but without a strong rotation catalyst to drive recovery near-term.

116. ?Jun 12, 6:04 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     LDOS (Leidos) is a well-established defense/IT services contractor with a history of stable government contracts and solid fundamentals; no recent news headlines or SEC filings suggest any company-specific deterioration driving the 20% drop from its 30-day high. The macro context shows a flattening yield curve (T10Y2Y at 0.42, 2σ below trend), which is consistent with a broad defensive-sector rotation or risk-off repositioning rather than any fundamental impairment at the company level. However, the absence of catalysts or news makes it difficult to assign high confidence to a near-term rebound, and the magnitude of the drop (20%) warrants caution without a clear re-rating trigger.

117. ❖Jun 12, 7:57 AMnewsvia finnhub

     1 Oversold Stock Ready to Bounce Back and 2 We Turn Down

     Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investor’s dilemma: bargain opportunity or value trap?

118. ?Jun 12, 7:03 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/IT services contractor with durable government contract revenue, making it fundamentally sound. The 20.3% drop from the 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment — no negative earnings guidance, no fraud, and no SEC filings indicating deterioration are present. However, confirmation signals are notably absent: no insider buying, options flow is nearly neutral (P/C ~1.02 at below-average volumes), and the sector (Industrials) is underperforming SPY over 30 days, suggesting the dip is partly sector-wide but without a strong rotation catalyst to drive recovery near-term.

119. ▣Jun 11, 8:00 PMjournalstop

     Agent 6 — Options Momentum closed long 100 @ $3.99 (-$11.38)

     Stop: premium $3.99 ≤ trailing floor $4.01 (peak $5.35 × 0.75)

120. ?Jun 11, 6:05 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/IT services contractor with durable government contract revenue, making it fundamentally sound. The 20.3% drop from the 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment — no negative earnings guidance, no fraud, and no SEC filings indicating deterioration are present. However, confirmation signals are notably absent: no insider buying, options flow is nearly neutral (P/C ~1.02 at below-average volumes), and the sector (Industrials) is underperforming SPY over 30 days, suggesting the dip is partly sector-wide but without a strong rotation catalyst to drive recovery near-term.

121. ?Jun 11, 6:04 PMdecisionconsidered

     Agent 4 — Dip Buyer (Frozen) — decide: skip

     LDOS (Leidos) is a well-established defense/IT services contractor with a history of stable government contracts and solid fundamentals; no recent news headlines or SEC filings suggest any company-specific deterioration driving the 20% drop from its 30-day high. The macro context shows a flattening yield curve (T10Y2Y at 0.42, 2σ below trend), which is consistent with a broad defensive-sector rotation or risk-off repositioning rather than any fundamental impairment at the company level. However, the absence of catalysts or news makes it difficult to assign high confidence to a near-term rebound, and the magnitude of the drop (20%) warrants caution without a clear re-rating trigger.

122. ❖Jun 11, 2:20 PMnewsvia finnhub

     Is Leidos Holdings, Inc. (LDOS) A Good Stock To Buy Now?

     Is LDOS a good stock to buy? We came across a bullish thesis on Leidos Holdings, Inc. on r/ValueInvesting by iloveaccounting64. In this article, we will summarize the bulls’ thesis on LDOS. Leidos Holdings, Inc.’s share was trading at $123.52 as of June 9th. LDOS’s trailing and forward P/E were 11.30 and 10.11 respectively according to Yahoo […]

123. ?Jun 11, 12:42 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/IT services contractor with durable government contract revenue, making it fundamentally sound. The 20.3% drop from the 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment — no negative earnings guidance, no fraud, and no SEC filings indicating deterioration are present. However, confirmation signals are notably absent: no insider buying, options flow is nearly neutral (P/C ~1.02 at below-average volumes), and the sector (Industrials) is underperforming SPY over 30 days, suggesting the dip is partly sector-wide but without a strong rotation catalyst to drive recovery near-term.

124. ?Jun 11, 12:42 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     Leidos is a well-established defense/government IT contractor with recurring revenue and solid fundamentals — the 20.3% drop from its 30-day high appears macro/sector-driven rather than tied to any confirmed fundamental impairment (no negative earnings guidance, no SEC filings indicating deterioration, and no insider selling). The Industrials sector has underperformed SPY by 2.7pts over 30 days, suggesting the dip is partly sector-wide rather than purely idiosyncratic. However, confirmation signals are absent: no insider cluster buys, options flow is neutral (P/C ratio ~1.02, both volumes below average z-scores), and there is no unusual call activity suggesting informed accumulation.

125. ❖Jun 10, 5:50 PMnewsvia finnhub

     Leidos (LDOS) Stock Moves -1.48%: What You Should Know

     Leidos (LDOS) reached $121.69 at the closing of the latest trading day, reflecting a -1.48% change compared to its last close.

126. ❖Jun 5, 8:15 PMnewsvia finnhub

     Leidos SATCOM Upgrade Raises Questions On Undervalued Shares And Debt Risks

     Leidos Holdings (NYSE:LDOS) has delivered a new Joint Management Tool to the U.S. military and defense agencies. The tool is designed to modernize satellite communications and operational oversight for global forces. JMT is now supporting the Department of War, DISA, and U.S. Space Command with real time situational awareness and more efficient SATCOM operations. For investors watching defense technology, this update puts Leidos Holdings (NYSE:LDOS) in focus as it rolls out a material...

127. ❖Jun 5, 5:25 PMnewsvia finnhub

     Leidos Holdings (LDOS) Secures $2.7B US Army Hypersonic Weapons Contract

     Leidos Holdings Inc. (NYSE:LDOS) is one of the most undervalued large cap stocks to buy according to analysts. On May 12, Reuters reported that Leidos Holdings was awarded a $2.7 billion contract by the US Army to transition hypersonic weapons from prototype development into full-scale production. These weapons are strategically critical due to their ability […]

128. ❖Jun 5, 2:19 PMnewsvia finnhub

     Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

     Get this week’s dividend updates for Champions, Contenders & Challengers—see hikes/cuts, upcoming ex-dividend dates and pay dates.

129. ❖Jun 5, 9:25 AMnewsvia finnhub

     Is BigBear.ai Emerging as a Key Homeland Security AI Stock?

     BBAI is ramping up homeland security AI, landing a $53M classified win as backlog climbs and secure genAI gains new government customers.

130. ❖Jun 4, 11:30 AMnewsvia finnhub

     Leidos (LDOS) Down 7.8% Since Last Earnings Report: Can It Rebound?

     Leidos (LDOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

131. ❖Jun 4, 11:27 AMnewsvia finnhub

     OSIS Gains From Robust Demand, Faces Margin and Timing Headwinds

     OSI Systems faces a Mexico program step-down, but a record $1.9B backlog and improving cash collections could reshape the next few quarters.

132. ❖Jun 4, 8:00 AMnewsvia finnhub

     New Leidos SATCOM tool boosts combat connectivity, effectiveness

     Combatants across the Department of War are gaining better access to satellite communications services through the Joint Management Tool (JMT) that Leidos (NYSE: LDOS) developed with the Defense Information Systems Agency (DISA) and U.S. Space Command.

133. ▢Jun 3, 8:00 PMjournal

     Agent 6 — Options Momentum opened long 100 @ $4.10

134. ❖Jun 3, 7:44 PMnewsvia finnhub

     Jefferies Downgrades Leidos Holdings (LDOS)

135. ❖Jun 3, 9:55 AMnewsvia finnhub

     Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls

     Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls

136. ❖Jun 3, 8:55 AMnewsvia finnhub

     Calls of the Day: Walmart, Ulta Beauty, Leidos Holdings and CME Group

     The Investment Committee debate the latest Calls of the Day.

137. ▢May 31, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 22 @ $131.40